These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24244294)

  • 1. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
    Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
    PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
    Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
    J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
    Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
    Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma.
    Li Y; Wang W; Wang W; Yang R; Wang T; Su T; Weng D; Tao T; Li W; Ma D; Wang S
    Gynecol Oncol; 2012 Jan; 124(1):112-8. PubMed ID: 22018873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of heterogeneous Twist2 expression in human breast cancers.
    Mao Y; Zhang N; Xu J; Ding Z; Zong R; Liu Z
    PLoS One; 2012; 7(10):e48178. PubMed ID: 23133563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-2α promotes epithelial-mesenchymal transition through regulating Twist2 binding to the promoter of E-cadherin in pancreatic cancer.
    Yang J; Zhang X; Zhang Y; Zhu D; Zhang L; Li Y; Zhu Y; Li D; Zhou J
    J Exp Clin Cancer Res; 2016 Feb; 35():26. PubMed ID: 26842802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways.
    Yan D; Avtanski D; Saxena NK; Sharma D
    J Biol Chem; 2012 Mar; 287(11):8598-612. PubMed ID: 22270359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells.
    Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A
    Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist1/2 activates MMP2 expression via binding to its promoter in colorectal cancer.
    Lu K; Dong JL; Fan WJ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8210-8219. PubMed ID: 30556860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCNP promotes ovarian cancer progression by accelerating β-catenin nuclear accumulation and triggering EMT transition.
    Dong P; Fu H; Chen L; Zhang S; Zhang X; Li H; Wu D; Ji X
    J Cell Mol Med; 2020 Jul; 24(14):8221-8235. PubMed ID: 32548978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence.
    Wang T; Li Y; Wang W; Tuerhanjiang A; Wu Z; Yang R; Yuan M; Ma D; Wang W; Wang S
    Hum Pathol; 2014 Sep; 45(9):1839-46. PubMed ID: 24974259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer.
    Shen CH; Wu JD; Jou YC; Cheng MC; Lin CT; Chen PC; Tseng YS; Shi CS; Chen SY; Chang DC; Lee YR
    J BUON; 2011; 16(4):733-7. PubMed ID: 22331730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.
    Wu Y; Ginther C; Kim J; Mosher N; Chung S; Slamon D; Vadgama JV
    Mol Cancer Res; 2012 Dec; 10(12):1597-606. PubMed ID: 23071104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
    Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
    Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
    Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
    BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TWIST2, E-cadherin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression.
    Li X; Yang J; Wang X; Li X; Liang J; Xing H
    Eur J Gynaecol Oncol; 2016; 37(1):100-8. PubMed ID: 27048119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
    Karbova E; Davidson B; Metodiev K; Tropé CG; Nesland JM
    Int J Surg Pathol; 2002 Jul; 10(3):175-80. PubMed ID: 12232570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway.
    Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M
    Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.